Clinical Trials Browser

Phase 1/2 × Immunoglobulin Light-chain Amyloidosis × 30 days × Clear all

NCT05145816 2026-05-07

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

Phase 1/2 Recruiting

Immunoglobulin Light-chain Amyloidosis, Amyloidosis